Soleno Therapeutics | 8-K: Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Soleno Therapeutics | 8-K: Current report
Soleno Therapeutics | 8-K: Current report
Soleno Therapeutics | DEF 14A: Definitive information statements
Soleno Therapeutics | 8-K: Current report
Soleno Therapeutics | 8-K: Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
Soleno Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Soleno Therapeutics | 8-K: Current report
Soleno Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Soleno Therapeutics | 8-K: Current report
Soleno Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Soleno Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Soleno Therapeutics | 8-K: Current report
Soleno Therapeutics | 8-K: Current report
Soleno Therapeutics | 8-K: Current report
Soleno Therapeutics | 8-K: Current report
Soleno Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Soleno Therapeutics | 8-K: Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
Soleno Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Soleno Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
No Data